Skip to content

Reduced background autofluorescence for cell imaging using nanodiamonds and lanthanide chelates

MetadataDetails
Publication Date2018-03-08
JournalScientific Reports
AuthorsNicole M. Cordina, Nima Sayyadi, Lindsay M. Parker, Arun Everest‐Dass, Louise J. Brown
InstitutionsMacquarie University, Griffith University
Citations65
AnalysisFull AI Review Included
  • Core Challenge Addressed: Cellular autofluorescence (450-670 nm) interferes with conventional fluorophore detection in bio-imaging, particularly in highly autofluorescent cells like brain endothelial tissue.
  • Nanodiamond Approach (NV Centers): Fluorescent nanodiamonds (FNDs) containing nitrogen-vacancy (NV) centers emit at ~700 nm, bypassing background autofluorescence via spectral separation.
  • Key Performance Finding: 30 nm FNDs coated with an E-selectin antibody achieved a 40-fold increase in signal intensity (AU 16.0 ± 8.8 vs. 0.4 ± 0.5) in TNFα-induced versus uninduced cells.
  • Lanthanide Alternative: Europium-chelating tags (BHHTEGST-Eu) leverage long luminescent lifetimes for time-gated imaging, achieving a 5.4× signal ratio between induced and uninduced cells when paired with multivalent SLeX-PAA-biotin.
  • Particle Size Principle: Despite 100 nm FNDs containing ~500 NV centers (~170× brighter per particle), the 30 nm particles demonstrated superior intracellular penetration and target specificity, illustrating that “bigger is not always better.”
  • Versatile Scaffold: A PEGylated streptavidin-biotin platform (FND-PEG-SA) enables universal attachment of any biotinylated ligand, allowing rapid adaptation to new biomolecular targets.
  • Functionalization Tolerance: Carboxylated FND surfaces (-COOH) accept standard EDC/NHS carbodiimide chemistry, enabling covalent PEG22 spacer arm attachment and downstream protein conjugation.
ParameterValueUnitContext
FND TypeType Ib synthetic diamond powder—Source material (Adamas Nano, Academia Sinica)
FND Sizes Tested30, 100nmTwo particle sizes compared
NV Centers (30 nm FND)1-3per particleLow NV loading due to volume constraints
NV Centers (100 nm FND)~500per particleHigh NV loading, ~170× brighter than 30 nm
NV Excitation Wavelength555 ± 12.5nmET555/25× Chroma filter
NV Emission Maxima~700nmAbove cellular autofluorescence range (450-670 nm)
NV Dichroic Cutoff635nmT635lpxr Chroma
Emission Bandwidth700 ± 37.5nmET700/75m Chroma collection filter
FND Surface ChemistryCarboxylated (-COOH)—Starting functional group for EDC/NHS coupling
Zeta Potential (30 nm FND-COOH)-40.4 ± 22.8mVMonodispersed colloidal stability
Zeta Potential (100 nm FND-COOH)-34.3 ± 7.0mVMonodispersed colloidal stability
Zeta Potential Threshold> |30|mVRequired for colloidal dispersion stability
DLS Size (30 nm FND-COOH)36.42 ± 8.96nmNumber-weighted distribution
DLS Size (30 nm FND-PEG22)52.55 ± 17.62nm+16.1 nm after PEGylation
DLS Size (30 nm FND-PEG22-SA)59.14 ± 17.85nm+6.6 nm after SA conjugation
DLS Size (100 nm FND-PEG22-SA)149.3 ± 25.6nmAfter full functionalization
PEG22 Spacer Length8-9nmExtended conformation size
Streptavidin Dimension~5nmLargest axis (PDB 3WYP)
EDC Concentration (activation)3.2mgPer 0.8 mg FND batch
NHS Concentration (activation)4.8mgPer 0.8 mg FND batch
EDC/NHS Reaction pH4—Acidic conditions for carboxyl activation
PEG Conjugation pH8—Basic DDW for amine coupling
DTT Quench Concentration50mMFinal concentration to inactivate EDC
PEG22 (CA(PEG)22) Mass4mgPer 0.8 mg FND batch
PEG Reaction Time3 + 16hrs3 hrs RT + 16 hrs at 4°C
Ethanolamine Quench50mMBlocks remaining NHS esters
Streptavidin Conjugation Mass100µgPer batch
Final FND-PEG-SA Concentration2mg/mLResuspended in neutral DDW
SA-BHHTEGST-Eu Working Conc.0.2mg/mLFor cell staining
BHHTEGST Molar Excess30-fold (max)—Beyond 30-fold causes precipitation
BHHTEGST:SA Final Ratio18:1mol/molSA-BHHTEGST18 achieved
BHHTEGST ε3353.14 × 104M-1cm-1Molar extinction at 335 nm
BHHTEGST ε2801.75 × 104M-1cm-1Molar extinction at 280 nm
Centrifugation Force16,000 × g—For FND pelleting
Centrifugation Time25minsPer wash cycle
DLS Laser Source633nmMalvern Zetasizer Nano ZS
Imaging Objective40× / 1.6 NA—Dry objective, Olympus BX63
Imaging Exposure (NV channel)14sConstant across all samples
TGL Exposure (Eu channel)5.0sASA 200, DP72 color camera
FND Conc. Standard Slope2242.9AU·mL/µgEmission at 678 nm vs. 530 nm excitation
TNFα Induction Dose20ng/mLCytokine for E-selectin upregulation
TNFα Induction Time4hrsOptimal expression window
Cell Seeding Density104cells/cm2bEnd.3 mouse brain endothelial cells
Fixative4% PFAv/v15 min fixation, non-permeabilized
Blocking AgentNormal horse serum100 µL/mL30 min for antibody experiments
Best Signal Ratio (30 nm FND-PEG-Ab)40×foldTNFα vs. uninduced
Best Eu Signal Ratio (multivalent SLeX)5.4×foldTNFα vs. uninduced
Background Noise (30 nm FND)0.04AUNegligible autofluorescence
Background Noise (100 nm FND)0.10AUNegligible autofluorescence
Background Noise (Eu chelate)1.28AUSlightly elevated baseline
Polydispersity Index< 0.3—Indicates monodispersity
  • Step 1 - Carboxylated FND Activation: Suspend 0.8 mg FND in acidic DDW (pH 4); incubate with 3.2 mg EDC and 4.8 mg NHS for 20 min at room temperature to activate -COOH groups.
  • Step 2 - EDC Quenching: Add DTT to a final concentration of 50 mM to inactivate excess EDC.
  • Step 3 - PEG22 Coupling: Pellet FND-NHS by centrifugation (16,000 × g, 25 min); resuspend in basic DDW (pH 8); add 4 mg CA(PEG)22 amino-PEG; agitate at 3,000 rpm for 3 hrs at RT, then 16 hrs at 4°C.
  • Step 4 - Quench Unreacted NHS: Add ethanolamine to 50 mM; incubate 2 hrs to cap residual NHS esters.
  • Step 5 - Streptavidin Conjugation: Reactivate terminal PEG carboxyls with EDC/NHS; couple 100 µg recombinant streptavidin at pH 8 for 3 hrs (3,000 rpm) + 16 hrs at 4°C.
  • Step 6 - Final Wash and Resuspension: Wash pellet by centrifugation (16,000 × g, 25 min); resuspend FND-PEG-SA in neutral DDW (pH 7) at 2 mg/mL.
  • Step 7 - Ligand Loading: Incubate 100 µL FND-PEG-SA (0.5 mg/mL) with 10 µL biotinylated SLeX (0.1 mg/mL) in PBS-BSA for 1 hr at 3,000 rpm.
  • Step 8 - Europium Alternative Scaffold: Mix 100 µg streptavidin in 100 mM NaHCO3 (pH 8.5) with 20-fold molar excess BHHTEGST; incubate 1 hr at 37°C; purify on Sephadex G-25 PD MiniTrap.
  • Step 9 - Cell Induction and Staining: Induce E-selectin in bEnd.3 cells with 20 ng/mL TNFα for 4 hrs; fix with 4% PFA for 15 min; incubate with 5 µL of 0.5 mg/mL probe for 2 hrs at 37°C.
  • Step 10 - Imaging Acquisition: Capture NV emission at 555 nm ex / 700 nm em with 14 s exposure; for Eu, use time-gated luminescence (5 s exposure) on Olympus BX51/BX63 platforms.
  • Applicable Materials:

    • This research utilized 30 nm and 100 nm Type Ib fluorescent nanodiamonds (FNDs) containing nitrogen-vacancy (NV) centers. For replication or scale-up of similar bio-imaging probes, 6CCVD supplies Optical Grade Single Crystal Diamond (SCD) and Polycrystalline Diamond (PCD) substrates that can be processed into nanodiamond feedstocks or used as bulk optical references.
    • The carboxylated surface chemistry required in this paper aligns with 6CCVD’s standard -COOH terminated diamond surfaces, ready for downstream EDC/NHS functionalization.
  • Customization Potential:

    • While this paper used standard 30 nm and 100 nm particle batches, 6CCVD offers custom diamond substrate dimensions up to 125 mm (PCD) with thickness ranges from 0.1 µm to 500 µm for SCD/PCD, ideal for fabricating specialized diamond platforms or wafer-scale NV center arrays.
    • Researchers requiring custom metallization for device integration (e.g., Ti/Pt/Au contact pads for in-situ electrical or plasmonic enhancement of NV emission) can leverage 6CCVD’s in-house metallization capabilities (Au, Pt, Pd, Ti, W, Cu).
    • For applications requiring precise particle morphology or thin-film formats, 6CCVD provides laser cutting services to dimension diamond substrates to exact specifications.
  • Engineering Support:

    • 6CCVD’s in-house PhD engineering team can assist with material selection for advanced biomedical imaging, quantum sensing, and NV-center based diagnostic platforms, including guidance on optimizing surface termination (carboxylated, hydrogen-terminated, or oxygen-terminated) for bioconjugation workflows.
    • For projects requiring ultra-smooth optical interfaces, 6CCVD’s polishing services achieve Ra < 1 nm (SCD) and < 5 nm (inch-size PCD), critical for minimizing scattering losses in fluorescence collection paths.
    • Whether scaling up from nanodiamond suspensions to bulk diamond sensors, or developing next-generation quantum-biological hybrid devices, 6CCVD provides consultative support across the full MPCVD material lifecycle.
  • Call to Action:

    • For custom specifications or material consultation, visit 6ccvd.com or contact our engineering team directly.
View Original Abstract

Bio-imaging is a key technique in tracking and monitoring important biological processes and fundamental biomolecular interactions, however the interference of background autofluorescence with targeted fluorophores is problematic for many bio-imaging applications. This study reports on two novel methods for reducing interference with cellular autofluorescence for bio-imaging. The first method uses fluorescent nanodiamonds (FNDs), containing nitrogen vacancy centers. FNDs emit at near-infrared wavelengths typically higher than most cellular autofluorescence; and when appropriately functionalized, can be used for background-free imaging of targeted biomolecules. The second method uses europium-chelating tags with long fluorescence lifetimes. These europium-chelating tags enhance background-free imaging due to the short fluorescent lifetimes of cellular autofluorescence. In this study, we used both methods to target E-selectin, a transmembrane glycoprotein that is activated by inflammation, to demonstrate background-free fluorescent staining in fixed endothelial cells. Our findings indicate that both FND and Europium based staining can improve fluorescent bio-imaging capabilities by reducing competition with cellular autofluorescence. 30 nm nanodiamonds coated with the E-selectin antibody was found to enable the most sensitive detective of E-selectin in inflamed cells, with a 40-fold increase in intensity detected.